Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Danaher - The Untold Story

US stocks today: US stocks end higher as semiconductors surge amid Mideast war intensifies

Wall Street closed higher as semiconductor stocks rebounded sharply, lifting major indexes despite tariff tensions and Middle East risks. Investors are positioning ahead of key tech earnings, betting on AI-driven growth. Gains in 3M and Hasbro contrasted with declines in Danaher and MSCI, highlighting mixed corporate signals.

The Economic Times

Stock Index Futures Climb as Chipmakers Extend Rebound, Earnings in Focus

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +1.39% this morning, pointing to a higher open on Wall Street as a rebound in chipmakers gained momentum.

Barchart

What to Expect From Danaher Corporation's Q1 2026 Earnings Report

Danaher Corporation is approaching its first-quarter earnings release in a few weeks, and Wall Street is forecasting a low single-digit percentage rise in earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

MarketBeat

These 3 Defensive Stocks Just Hit 52-Week Highs — Should You Lock In Gains?

High PEG ratios indicate that many defensive stocks in health care and consumer staples trade at stretched valuations. With earnings growth lagging price momentum, three stand out as candidates for profit-taking while the market’s risk appetite begins to shift.

Barchart

Health Care Stocks Have Sagged. Can You Bet on a Recovery?

The flagging health care sector has perked up a bit lately. Is it time to invest?

Kiplinger

How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks?

Danaher Corporation faces near-term relative weakness, but the Street’s conviction suggests recovery ahead.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is It Too Late to Chase Masimo Stock on Major Danaher News?

Masimo stock rallies as Danaher announces plans of buying the health tech firm for $180 a share in cash. But is there any further upside left in MASI shares?

Barchart

Stocks Recover on Strength in Apple and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.10%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. March E-mini S&P futures (ESH26 ) rose +0.12%, and March E-mini Nasdaq futures...

Barchart

Stocks Fall as AI Concerns Dampen Market Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.10%. March E-mini S&P futures (ESH26 ) are down -0.62%, and March E-mini Nasdaq futures...

Barchart

Danaher Stock: Is DHR Underperforming the Healthcare Sector?

Despite Danaher’s underperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.

Benzinga

Danaher Reports Strong Q3 Earnings, Shares Move Higher

Danaher Corporation (NYSE:DHR) shares are rising Tuesday after the company reported better-than-expected third-quarter financial results.

Benzinga

Earnings Preview: What To Expect From Danaher's Report

Healthcare giant Danaher is gearing up to announce its Q3 results in the upcoming week, and analysts expect its earnings growth to remain mostly flat.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Danaher Stock Underperforming the Dow?

Although Danaher has lagged behind the Dow over the past year, analysts remain bullish about the stock’s prospects.

Benzinga

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion.

Barchart

S&P Futures Muted With Focus on Earnings and Trade Deals

September S&P 500 E-Mini futures (ESU25) are trending down -0.04% this morning as investors brace for a raft of corporate earnings reports and continue to keep a close eye on any trade developments between the U.S. and key trading partners as the August 1st deadline approaches.

Benzinga

Jim Cramer 'Worried' About Workday, Calls Applied Digital 'A Good Spec'

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended staying away from Workday, Inc. (NASDAQ:WDAY). “I'm worried. There's a lot of companies coming for Workday, and I don't like that,” he added.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Danaher Stock Outperforming the Nasdaq?

Danaher has notably underperformed the Nasdaq composite over the past year, yet analysts remain highly optimistic about the stock’s long-term prospects.

Barchart

Stocks Rebound Sharply on Trade Deal Optimism

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +2.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +2.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.63%. June E-mini S&P futures (ESM25 ) are up +2.52%, and June E-mini Nasdaq futures...

Barchart

Stocks Climb on Trade Deal Optimism and Strong Q1 Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +1.82%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.13%. June E-mini S&P futures (ESM25 ) are up +1.98%, and June E-mini Nasdaq futures...

Barchart

Danaher's Q1 2025 Earnings: What to Expect

Danaher is all set to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit decline.

Barchart

Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian buy.

Barchart

Is Danaher Stock Underperforming the S&P 500?

Although Danaher has underperformed the S&P 500 Index over the past year, analysts remain bullish about the stock’s prospects.

MarketBeat

3 Stocks Offering Strong Value and Stability

These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

the Wall Street Journal

1,366 stories

Dow

1,254 stories

Warner Bros Discovery

1,015 stories

the Financial Times

637 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.